Belchim strongly believes it is important that projects are developed and
registered close to the market, and collaboration between R&D, marketing
and the sales organisation is crucial to ensuring that the solutions that
end up ready for the market, are what the market needs. To foster this
collaboration, Belchim has a function called Portfolio Management, with
managers assigned to each product segment, acting as a bridge between
functions.
In order to maintain a strong late-stage pipeline, Belchim invests significantly
in the evaluation of many proposals for early stage projects, whether they
be from third parties, new formulation concepts of existing products, or
other ideas. For example, in 2021, 52 early stage proposals were received
and reviewed; 22 biological products, 20 conventional products and 10 new
formulation concepts.
5 years to market
6 to 10 years to market
Launch
Commercialisation
Pre-commercial phase
39




